SNDL (DB:VY4) - Prezzo delle azioni, notizie e analisi

VY4 Panoramica delle azioni

SNDL Inc. si occupa di produzione, distribuzione e vendita di prodotti a base di cannabis in Canada.

VY4 analisi fondamentale
Punteggio fiocco di neve
Valutazione	3/6
Crescita futura	0/6
Prestazioni passate	0/6
Salute finanziaria	6/6
Dividendi	0/6

Premi

Negoziato a un buon valore rispetto ai pari e al settore

Analisi del rischio

Attualmente non redditizio e non si prevede che diventerà redditizio nei prossimi 3 anni

SNDL Inc. Concorrenti

PharmaSGP Holding

XTRA:PSG

€299.8m

MPH Health Care

DB:93M1

€106.2m

Dermapharm Holding

XTRA:DMP

€1.6b

Pierrel

DB:2FJ0

€92.8m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per SNDL
Prezzi storici delle azioni
Prezzo attuale dell'azione	US$2.01
Massimo di 52 settimane	US$2.70
Minimo di 52 settimane	US$1.20
Beta	3.18
1Variazione di 1 mese	12.33%
Variazione a 3 mesi	-4.55%
Variazione di 1 anno	48.63%
3Variazione a 3 anni	-64.85%
Variazione a 5 anni	-92.31%
Variazione dall'IPO	-97.11%

Notizie e aggiornamenti recenti

Recent updates

Rendimenti per gli azionisti

	VY4	DE Pharmaceuticals	DE Mercato
7D	2.4%	-4.1%	-1.0%
1Y	48.6%	-11.4%	16.1%

Ritorno vs Industria: VY4 ha superato il German Pharmaceuticals che ha restituito -11.4 % nell'ultimo anno.

Rendimento vs Mercato: VY4 ha superato il mercato German che ha restituito 16.1 % nell'ultimo anno.

Volatilità dei prezzi

Is VY4's price volatile compared to industry and market?
VY4 volatility
VY4 Average Weekly Movement	5.7%
Pharmaceuticals Industry Average Movement	7.7%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	10.8%
10% least volatile stocks in DE Market	2.5%

Prezzo delle azioni stabile: VY4 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 6% ) di VY4 è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
2006	2,516	Zach George	www.sndlgroup.com

SNDL Inc. si occupa di produzione, distribuzione e vendita di prodotti a base di cannabis in Canada. La società opera attraverso i segmenti Liquor Retail, Cannabis Retail, Cannabis Operations e Investments. L'azienda si occupa di coltivazione, distribuzione e vendita di cannabis per uso medico e per adulti; vende vini, birre e liquori attraverso negozi di liquori di proprietà; vende cannabis per uso ricreativo attraverso negozi di cannabis al dettaglio di proprietà e in franchising.

SNDL Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di SNDL con la sua capitalizzazione di mercato?
VY4 statistiche fondamentali
Capitalizzazione di mercato	€542.19m
Guadagni(TTM)	-€74.79m
Ricavi(TTM)	€604.07m

0.9x

Rapporto P/S

-7.0x

Rapporto P/E

VY4 è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
VY4 Conto economico (TTM)
Ricavi	CA$911.92m
Costo del fatturato	CA$697.42m
Profitto lordo	CA$214.51m
Altre spese	CA$327.40m
Guadagni	-CA$112.90m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

Nov 05, 2024

Utile per azione (EPS)	-0.43
Margine lordo	23.52%
Margine di profitto netto	-12.38%
Rapporto debito/patrimonio netto	0%

Come si è comportato VY4 nel lungo periodo?

Vedi performance storica e confronto

VY4 Panoramica delle azioni

Premi

Analisi del rischio

SNDL Inc. Concorrenti

XTRA:PSG

€299.8m

DB:93M1

€106.2m

XTRA:DMP

€1.6b

DB:2FJ0

€92.8m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

SNDL Inc. to Report Q3, 2024 Results on Nov 05, 2024

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of 34.80% stake in Nova Cannabis Inc. (TSX:NOVC).

SNDL Inc. Appoints J. Carlo to Its Board of Directors

No longer forecast to breakeven

SNDL Inc. (NasdaqCM:SNDL) agreed to acquire 34.80% stake in Nova Cannabis Inc. (TSX:NOVC) for CAD 72.39 million.

SNDL Inc. to Report Q2, 2024 Results on Aug 02, 2024

Recent updates

SNDL Inc. to Report Q3, 2024 Results on Nov 05, 2024

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of 34.80% stake in Nova Cannabis Inc. (TSX:NOVC).

SNDL Inc. Appoints J. Carlo to Its Board of Directors

No longer forecast to breakeven

SNDL Inc. (NasdaqCM:SNDL) agreed to acquire 34.80% stake in Nova Cannabis Inc. (TSX:NOVC) for CAD 72.39 million.

SNDL Inc. to Report Q2, 2024 Results on Aug 02, 2024

SNDL Inc., Annual General Meeting, Jul 30, 2024

New major risk - Revenue and earnings growth

SNDL Inc. Reports Asset Impairment Charges for the First Quarter Ended March 31, 2024

First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.13 loss in 1Q 2023)

SNDL Inc. to Report Q1, 2024 Results on May 09, 2024

Full year 2023 earnings released: CA$0.67 loss per share (vs CA$1.46 loss in FY 2022)

SNDL Inc. to Report Fiscal Year 2023 Results on Mar 21, 2024

Third quarter 2023 earnings released: CA$0.08 loss per share (vs CA$0.41 loss in 3Q 2022)

SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 13,100,000 shares, representing 5% for CAD 100 million.

SNDL Inc. to Report Q3, 2023 Results on Nov 13, 2023

SNDL Inc. Launches New E-Commerce Platform for its Destination Liquor Retail banner, Wine and Beyond

Second quarter 2023 earnings released: CA$0.12 loss per share (vs CA$0.31 loss in 2Q 2022)

SNDL Inc. to Report Q2, 2023 Results on Aug 14, 2023

New major risk - Share price stability

SNDL Inc. Announces Chief Financial Officer Changes

SNDL Inc., Annual General Meeting, Jul 27, 2023

SNDL Inc. to Report Q1, 2023 Results on May 15, 2023

Forecast breakeven date moved forward to 2023

Forecast breakeven date moved forward to 2023

Forecast breakeven date moved forward to 2023

SNDL Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of Substantially all of the business and assets of Superette.

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining 91.9% stake in The Valens Company Inc. (TSX:VLNS).

SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 11,800,000 shares, representing 5% for CAD 100 million.

Sundial Growers Inc. (NasdaqCM:SNDL) acquired Zenabis Global Inc. from HEXO Corp. (TSX:HEXO).

SNDL Inc. to Report Q3, 2022 Results on Nov 14, 2022

SNDL Inc. (NasdaqCM:SNDL) entered into a Stalking Horse Agreement to acquire Substantially all of the business and assets of Superette.

SNDL Inc. (NasdaqCM:SNDL) entered into an arrangement agreement to acquire remaining 89.9% stake in The Valens Company Inc. (TSX:VLNS) for CAD 92.1 million.

SNDL Inc. to Report Q2, 2022 Results on Aug 12, 2022

Sundial Growers Inc. Announces Resignation of David Gordey as Chief Administrative Officer, Effective July 29, 2022

Simply Solventless Concentrates Ltd. completed the acquisition of Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc.. from Sundial Growers Inc. (NasdaqCM:SNDL).

Sundial Growers Inc. (NasdaqCM:SNDL) entered into a purchase agreement to acquire Zenabis Global Inc. from HEXO Corp. (TSX:HEXO).

Sundial Growers Inc. to Report Q1, 2022 Results on May 16, 2022

Sundial Growers Inc., Annual General Meeting, Jun 27, 2022

Sundial Growers Inc. to Report Q4, 2021 Results on Apr 14, 2022

Sundial Receives 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Rule

Simply Solventless Concentrates Ltd. entered into an asset purchase agreement to acquire Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc. from Sundial Growers Inc. (NasdaqCM:SNDL) for CAD 5 million.

An unknown byer acquired 25% stake in Pathway RX Inc from Sundial Growers Inc. (NasdaqCM:SNDL).

Sundial Growers Inc. (NasdaqCM:SNDL) entered into an agreement to acquire Inner Spirit Holdings Ltd. (CNSX:ISH) for approximately CAD 120 million.

Sundial and SAF Group Announce Strategic Capital Partnership

Sundial Growers Inc. to Report Q4, 2020 Results on Mar 17, 2021

Sundial Regains Compliance with Nasdaq Minimum Bid Price Rule

Sundial Growers Inc. has completed a Composite Units Offering in the amount of $100 million.

Sundial Growers Inc. Announces the Launch of Premium Concentrates Products Under Its Top Leaf Brand

Sundial Growers Inc. (NasdaqCM:SNDL) acquired Senior Secured Loans of Zenabis Investments Ltd for CAD 58.9 million.

Sundial Announces Concentrates Licence Agreement with Simply Solventless

Sundial Growers Transfers Listing to Extend Regaining Compliance Period

New 90-day high: €0.60

Revenue misses expectations

Third quarter 2020 earnings released: CA$0.53 loss per share

Sundial Growers Inc. Enters into Sales and Distribution Agreement with Choklat Inc

Sundial Growers Inc. to Report Q3, 2020 Results on Nov 11, 2020

David Ball, together with the senior management team of Bridge Farm Nurseries and Artemis Growth Partners reached an agreement to acquire Bridge Farm Nurseries Limited from Sundial Growers Inc. (NasdaqGS:SNDL) for CAD 90 million.